Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis

PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
LeukemiaFungal Infection
Interventions
DRUG

Voriconazole

Starting dose of 400 mg by mouth twice a day for first day, followed by 200 mg by mouth twice a day thereafter.

DRUG

Voriconazole

6 mg/kg by vein for first dose, followed by 200 mg by mouth twice a day thereafter.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER